Skip to main content
LXRX
NASDAQ Life Sciences

Lexicon Pharmaceuticals Secures $100M Non-Dilutive Loan Facility from Hercules Capital

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.68
Mkt Cap
$677.889M
52W Low
$0.514
52W High
$1.95
52W Position info
227% above low
Off High info
14% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

LXRX has more than doubled off its 52-week low of $0.514.

Summary

Lexicon Pharmaceuticals announced a new loan facility with Hercules Capital (HTGC) providing up to $100 million in borrowing capacity. An initial $55 million tranche was funded at closing to repay an existing loan, with the remaining $45 million available in tranches upon achieving certain clinical, regulatory, and financial milestones. This non-dilutive financing significantly enhances Lexicon's financial flexibility, offering an extended interest-only period and a maturity date of May 2030. This is a material capital event for Lexicon, supporting its upcoming regulatory and commercial milestones for its late-stage cardiometabolic programs. Traders should monitor the company's progress on these milestones to assess the draw-down of the additional tranches and the strategic deployment of this capital.

At the time of this announcement, LXRX was trading at $1.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $677.9M. The 52-week trading range was $0.51 to $1.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LXRX - Latest Insights

LXRX
Nov 05, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1106 (-7%) info
Market Cap: $681.209M info
LXRX
Nov 05, 2026, 7:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1075 (-7%) info
Market Cap: $681.209M info
LXRX
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1075 (-7%) info
Market Cap: $681.209M info
LXRX
Aug 31, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.50 info
Change: -$0.7975 (-35%) info
Market Cap: $681.209M info
LXRX
Aug 24, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.38
Real-time Price: $1.50 info
Change: -$0.8775 (-37%) info
Market Cap: $681.209M info